Home » Topics » BioWorld Science

BioWorld Science
RSS

Fochon Pharma advances new anticancer Bcl-2, CDK4/6 inhibitors

April 23, 2019

FDA accepts IND for HER2-targeting engineered toxin body MT-5111

April 23, 2019

Forbius doses first patient with triple-negative breast cancer in phase IIa trial of AVID-100

April 23, 2019

FDA approves Keytruda for use with Inlyta in first-line advanced renal cell carcinoma

April 23, 2019

Topline results from phase III study of tanezumab in osteoarthritis

April 23, 2019

TXA-9155 potentiates antibiotics against Pseudomonas aeruginosa

April 23, 2019

Phase IIb data presented for CT-P27 in adults with influenza A infection

April 23, 2019

BioAtla's conditionally active biologics show tumor-specific activity in vivo

April 23, 2019

Zonula presents CDH2 antagonists

April 23, 2019

Zhejiang Hisun Pharmaceutical divulges new SCN9A blockers

April 23, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...